Search - tctmd.com

Displaying 161 - 180 of 416

Sort: Relevancy | Date

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

Yael L. Maxwell

January 10, 2020

News Daily News

SCAI Experts Update Transradial Guidance

Yael L. Maxwell

January 03, 2020

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Shelley Wood

October 14, 2019

News Daily News

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

Todd Neale

October 14, 2019

News Daily News

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

Todd Neale

October 10, 2019

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Daily News

SCAI Shock Definition Tracks Well With Mortality in Cardiac ICU

Todd Neale

September 24, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Yael L. Maxwell

August 31, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

Advertisement

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

SCAI Experts Update Transradial Guidance

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

SCAI Shock Definition Tracks Well With Mortality in Cardiac ICU

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content